ABT Jan 2025 95.000 call
| Previous Close | 26.00 |
| Open | 26.00 |
| Bid | 26.95 |
| Ask | 28.30 |
| Strike | 95.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 26.00 - 26.00 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 13 |
- ACCESSWIRE
The Virus Hunt: New Video Series Highlights Abbott Pandemic Defense Coalition
The Abbott Pandemic Defense Coalition is working nonstop at the front lines of virus surveillance and prevention to help stop outbreaks before they become pandemics.
- Motley Fool
Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023?
Abbott Laboratories (NYSE: ABT) has generally been a good investment to hold over the years. Is Abbott a bad-news buy that could turn things around in 2023, or has this once-safe healthcare stock become too risky of an investment to be holding right now? Last month, Abbott reported its fourth-quarter and year-end results for 2022.
- Motley Fool
Is This Dividend King a Buy for Income Investors?
No matter which way the market goes, the payouts of companies with decades of dividend growth behind them tend to go in one direction: up. Abbott Laboratories' (NYSE: ABT) 50-year dividend growth streak makes it one of just 43 Dividend Kings. With 113,000 employees and a presence in more than 160 countries, Abbott is among the largest healthcare companies in the world.
